VYNE Therapeutics
VYNE
VYNE
35 hedge funds and large institutions have $23.4M invested in VYNE Therapeutics in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.93% less ownership
Funds ownership: 49.82% → 47.9% (-1.9%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$823K | |
| 2 | +$516K | |
| 3 | +$144K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$124K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$106K |
Top Sellers
| 1 | -$505K | |
| 2 | -$287K | |
| 3 | -$207K | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$168K |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$144K |